Loading organizations...
Red Capital operates as a specialized venture capital firm, focused on cultivating investment portfolios within the healthcare sector. The firm strategically deploys capital to support emerging companies across the life sciences ecosystem, aiming to accelerate the development and market adoption of innovative technologies and solutions. Its core activity involves identifying promising ventures and providing financial backing coupled with strategic guidance.
The firm's establishment details, including its founding date and the full names of its founders, are not publicly disclosed. The particular insight that led to its formation, along with any specific founder pedigrees, are not readily available through current information.
Red Capital primarily serves companies operating within the life sciences and healthcare domains, acting as a crucial financial partner and growth facilitator. The firm's overarching mission is to advance innovation throughout the entire life sciences ecosystem, envisioning a future where groundbreaking discoveries are efficiently brought to fruition, ultimately benefiting patients and the broader healthcare landscape.
Red Capital has 1 tracked investment across 1 company. The latest tracked deal is $5.0M Series B in N.B.Medical in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 26, 2026 | N.B.Medical | $5.0M Series B | — | AIST Solutions, ANRI, Jafco Ventures, Mitsubishi UFJ Capital, Reazon Holdings |